A study of the junction between glutaraldehyde-treated allogeneic aorta and host aorta

Journal of Heart Valve Disease

Volumn 9, Issue 4, 2000, Pages 570-575

  Grobe, Albert C ^a   Cheung, David T ^a   Luo, Hong He ^a   Shomura, Yu ^a   Marchion, Douglas C ^a   Pfau, Jean C ^a   Duran, Carlos M G ^a,b  

^a UNIVERSITY OF MONTANA   (United States)

^b St Patrick Hospital and Health Sciences Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; GLUTARALDEHYDE; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA GRAFT; ARTICLE; BIOPROSTHESIS; CALCIFICATION; CELL DEATH; CONTROLLED STUDY; EXPLANT; FIBROSIS; HEALING; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ACTINS; ANIMALS; AORTA, THORACIC; AORTIC VALVE; BIOPROSTHESIS; CALCINOSIS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; SHEEP; STENTS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VON WILLEBRAND FACTOR;

EID: 0033853842     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Westaby S, Jin XY. Haemodynamic performance and versatility of the porcine aortic root. In: Huysmans H, David TE, Westaby S. (eds.). Stentless Bioprostheses. 2nd edn. Isis Medical Media, Oxford, UK, 1999:109-119
2. Cartier PC, Metras J, Dumesnil JG, Doyle D, Desaulniers D, Lemieux M, Raymond G. Clinical and haemodynamic performance of the Freestyle aortic root bioprosthesis. In: Huysmans H, David TE, Westaby S. (eds.). Stentless Bioprostheses. 2nd edn. Isis Medical Media, Oxford, UK, 1999:153-159
3. Westaby S. The stentless aortic bioprosthesis. In: Piwnica A, Westaby S (eds.). Surgery for Acquired Aortic Valve Disease. Isis Medical Media, Oxford, UK, 1997:83-101
4. Levy RJ. Glutaraldehyde and the calcification mechanism of bioprosthetic heart valves. J Heart Valve Dis 1994;3:101-104
5. Binet JP, Duran CG, Carpentier A, Langlois J. Heterologous aortic valve transplantation. Lancet 1965;2:1275
6. O'Brien MF, Clarebrough JK. Heterograft aortic valve transplantation for human valve disease. Med J Aust 1966;2:228-230
7. Carpentier A, Blondeau P, Laurens P, Mancel P, Laurent D, Dubost C. Remplacement des valves mitrales et tricuspides par des heterogreffes. Ann Chir Thorac Cardiovasc 1968;7:33-38
8. Reis RL, Hancock WD, Yarbrough JW, Glancy DL, Morrow AG. The flexible stent. A new concept in the fabrication of tissue heart valve prosthesis. J Thorac Cardiovasc Surg 1971;62:683-689
9. Duran CMG, Gallo I, Ruiz B, Revuelta JM, Ochoteco A. A thousand porcine bioprosthesis revisited. Do they conform with the expected pattern? In: Cohn LH, Gallucci V (eds.). Cardiac Bioprosthesis. Yorke Medical Books, New York, 1982:35-41
10. Schoen FJ. Aortic valve structure-function correlations: Role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis 1997;6:1-6
11. Myers D. New tissue-processing techniques. In: Piwnica A, Westaby S (eds.). Surgery for Acquired Aortic Valve Disease. Isis Medical Media, Oxford, UK, 1997:448-459
12. Duran CMG, Gunning AJ. Homologous aortic valve transplantation in the dog. Br Heart J 1964;26:135-136
13. Duran CMG, Gunning AJ. Heterologous aortic-valve transplantation in the dog. Lancet 1965;2:114-115
14. Walther T, Falk V, Gunther B, Diegeler A, Rauch T, van Son JAM, Mohr FW. Anticalcification treatments for stentless bioprosthesis. In: Huysmans H, David TE, Westaby S. (eds.) Stentless Bioprostheses. 2nd edn. Isis Medical Media, Oxford, UK, 1999:235-240
15. Doty DB, Flores JH, Millar RC. Aortic valve replacement with the Medtronic Freestyle bioprosthesis. In: Huysmans H, David TE, Westaby S. (eds.). Stentless Bioprostheses. 2nd edn. Isis Medical Media, Oxford, UK, 1999:93-101
16. Carpentier A, Lemaigre CG, Robert L, Carpentier S, Dubost C. Biological factors affecting long term results of valvular heterografts. J Thorac Cardiovasc Surg 1969;58:467-483
17. Huang-Lee LL, Cheung DT, Nimni ME. Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived crosslinks. J Biomed Mater Res 1990;24:1185-1201
18. Gendler E, Gendler S, Nimni ME. Toxic reactions evoked by glutaraldehyde-fixed pericardium and cardiac valve tissue bioprosthesis. J Biomed Mater Res 1984;18:727-736
19. Kim KM, Herrera GA, Battarbee HD. Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Path 1999;154:843-852
20. Levy RJ, Schoen FJ, Anderson HC, et al. Cardiovascular implant calcification: A survey and update. Biomaterials 1991;12:707-713
21. Schoen FJ, Harasaki H, Kim KM, Anderson HC, Levy RJ. Biomaterial-associated calcification: Pathology, mechanisms, and strategies for prevention. J Biomed Mater Res 1988;22:11-36
22. Frasca P, Buchanan JW, Soriano RZ, et al. Morphological observations of mineralizing pericardium cardiac grafts. Scan Electron Microsc 1985;3:1253-1258